ホーム > 金子新/ Kaneko, Shin

金子新

Kaneko, Shin

iPS細胞研究所増殖分化機構研究部門免疫再生治療分野 , 教授
Regenerative Immunotherapy (Shin Kaneko Lab), Dept. Cell Growth and Differentiation, Center for iPS cell Research and Application (CiRA) , Professor

21. Humanized mouse models with endogenously developed human natural killer cells for in vivo immunogenicity testing of HLA class I-edited iPSC-derived cells. Charlotte Flahou; Tatsuya Morishima; Natsumi Higashi; Yoshikazu Hayashi (+13 著者) Naoshi Sugimoto
Biochemical and biophysical research communications 662: 76 (2023) Semantic Scholar
22. Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells. Tatsuki Ueda; Sara Shiina; Shoichi Iriguchi; Seitaro Terakura (+15 著者) Shin Kaneko
Nature biomedical engineering 7: 24 (2023) Semantic Scholar
23. Improved anti-solid tumor response by humanized anti-podoplanin chimeric antigen receptor transduced human cytotoxic T cells in an animal model. Akihiro Ishikawa; Masazumi Waseda; Tomoko Ishii; Mika K Kaneko (+1 著者) Shin Kaneko
Genes to cells : devoted to molecular & cellular mechanisms 27: 549 (2022) Semantic Scholar
24. Development of B-cell maturation antigen (BCMA)-specific CD8⁺ cytotoxic T lymphocytes using induced pluripotent stem cell technology for multiple myeloma. Jooeun Bae; Shuichi Kitayama; Zach Herbert; Laurence Daheron (+3 著者) Kenneth Carl Anderson
Journal of Clinical Oncology 40: 2542 - 2542 (2022) Semantic Scholar
25. Sustainable Antiviral Efficacy of Rejuvenated HIV-Specific Cytotoxic T Lymphocytes Generated from Induced Pluripotent Stem Cells. Shoji Miki; Yohei Kawai; Kaori Nakayama-Hosoya; Ryutaro Iwabuchi (+5 著者) Ai Kawana-Tachikawa
Journal of virology 96: e0221721 (2022) Semantic Scholar
26. The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-1derived iPS cells Takeshi Ito; Yohei Kawai; Yutaka Yasui; Shoichi Iriguchi (+7 著者) Shin Kaneko
Communications Biology 4: (2021) Semantic Scholar
27. Induced pluripotent stem cell-derived natural killer cells gene-modified to express chimeric antigen receptor-targeting solid tumors Tatsuki Ueda; Shin Kaneko
International Journal of Hematology 114: 572 (2021) Semantic Scholar
28. Generation of highly proliferative, rejuvenated cytotoxic T cell clones through pluripotency reprogramming for adoptive immunotherapy. Yohei Kawai; Ai Kawana-Tachikawa; Shuichi Kitayama; Tatsuki Ueda (+2 著者) Shin Kaneko
Molecular therapy : the journal of the American Society of Gene Therapy 29: 3027 (2021) Semantic Scholar
29. Generation of macrophages with altered viral sensitivity from genome-edited rhesus macaque iPSCs to model human disease. Yoshihiro Iwamoto; Yohei Seki; Kahoru Taya; Masahiro Tanaka (+7 著者) Shin Kaneko
Molecular therapy. Methods & clinical development 21: 262 (2021) Semantic Scholar
30. Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy. Hiroaki Mashima; Rong Zhang; Tsuyoshi Kobayashi; Hirotake Tsukamoto (+10 著者) Yasushi Uemura
Molecular therapy. Methods & clinical development 21: 171 (2021) Semantic Scholar
31. Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells Bo Wang; Shoichi Iriguchi; Masazumi Waseda; Norihiro Ueda (+11 著者) Shin Kaneko
Nature Biomedical Engineering 5: 429 (2021) Semantic Scholar
32. Capturing human trophoblast development with naive pluripotent stem cells in vitro Shingo Io; Mio Kabata; Yoshiki Iemura; Katsunori Semi (+15 著者) Yasuhiro Takashima
Cell Stem Cell 28: 1023 (2021) Semantic Scholar
33. Engineering of human induced pluripotent stem cells via human artificial chromosome vectors for cell therapy and disease modeling. Yasuhiro Kazuki; Narumi Uno; Satoshi Abe; Naoyo Kajitani (+17 著者) Kazuma Tomizuka
Molecular therapy. Nucleic acids 23: 629 (2021) Semantic Scholar
34. A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy Shoichi Iriguchi; Yutaka Yasui; Yohei Kawai; Suguru Arima (+15 著者) Shin Kaneko
Nature communications 12: 430 (2021) Semantic Scholar
35. Feeder-free differentiation and expansion for T cells from induced pluripotent stem cells Shoichi Iriguchi; Yutaka Yasui; Yohei Kawai; Suguru Arima (+15 著者) Shin Kaneko
(2021) Semantic Scholar
36. Podoplanin as an Attractive Target of CAR T Cell Therapy Masazumi Waseda; Shin Kaneko
Cells 9: 1971 (2020) Semantic Scholar
37. Non–clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti–glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells Tatsuki Ueda; Ayako Kumagai; Shoichi Iriguchi; Yutaka Yasui (+12 著者) Shin Kaneko
Cancer Science 111: 1478 (2020) Semantic Scholar
38. Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response Hiroaki Mashima; Rong Zhang; Tsuyoshi Kobayashi; Yuichiro Hagiya (+14 著者) Yasushi Uemura
OncoImmunology 9: 1814620 (2020) Semantic Scholar
39. Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells. Nobuhiro Tsuchiya; Rong Zhang; Tatsuaki Iwama; Norihiro Ueda (+20 著者) Yasushi Uemura
Cell reports 29: 162 (2019) Semantic Scholar
40. Junctional Adhesion Molecule 2 Represents a Subset of Hematopoietic Stem Cells with Enhanced Potential for T Lymphopoiesis. Visnja Radulovic; Mark van der Garde; Shuhei Koide; Valgardur Sigurdsson (+2 著者) Kenichi Miharada
Cell reports 27: 2826 (2019) Semantic Scholar

« 1 2 3 4 … 6 »

1. In Vitro Detection of Cellular Adjuvant Properties of Human Invariant Natural Killer T Cells Rong Zhang; Shuichi Kitayama; Tianyi Liu; Norihiro Ueda; Yumi Tokumitsu; Hiroaki Mashima; Hideki Ohdan; Shin Kaneko; Yasushi Uemura (担当:分担執筆)
Humana Press Inc. 2019年
2. In Vitro Differentiation of T Cells: From Human Embryonic Stem Cells and Induced Pluripotent Stem Cells Shoichi Iriguchi; Shin Kaneko (担当:分担執筆)
Humana Press Inc. 2019年
3. Differentiating CD8αβ T Cells from TCR-Transduced iPSCs for Cancer Immunotherapy Atsutaka Minagawa; Shin Kaneko (担当:分担執筆)
Humana Press Inc. 2019年
4. In Vitro Differentiation of T Cells: From Nonhuman Primate-Induced Pluripotent Stem Cells Shoichi Iriguchi; Shin Kaneko (担当:分担執筆)
Humana Press Inc. 2019年
5. In Vitro Differentiation of T Cell: From CAR-Modified T-iPSC Tatsuki Ueda; Shin Kaneko (担当:分担執筆)
Humana Press Inc. 2019年
6. Redifferentiation of Adaptive Naïve-Like CTL from T-Cell-Derived iPSC Yohei Kawai; Shin Kaneko (担当:分担執筆)
Humana Press Inc. 2019年

1. アカデミア発のイノベーションを社会実装する試み金子新
LINK-Jシンポジウム「創薬のフロンティア2025」 2025年6月30日招待有り
2. Advancements in science & technology サイエンス・テクノロジーの進展金子新
EXPO2025Theme weeks 健康とウェルビーイングウィーク 2025年6月28日招待有り
3. Development of iPS Cell-based T Cell Therapy Product for Controlling Antigen-specific Immunity 金子新
FOCIS 2025 Annual Meeting 2025年6月25日招待有り
4. 日本発創薬最前線～グローバルとつながる金子新
NIKKEI 創薬エコシステムサミット 2025年6月25日招待有り
5. iPS細胞を使った新しいがん免疫治療研究金子新
サイエンスカフェ「iPS細胞と次世代医療で健康な未来をつくる」 2025年6月21日招待有り
6. The generation of T cells from iPS cells for immunotherapy
2025 Taiwan Regenerative Medicine Summit 2025年4月10日招待有り
7. スタートアップの立場から、グローバルも含むiPS細胞由来製品開発金子新
再生医療イノベーションフォーラム（FIRM）メディア懇談会 2025年3月25日招待有り
8. スタートアップから見た創薬～がん免疫治療とiPS細胞金子新
第36回製薬協政策セミナー 2025年3月17日招待有り
9. iPS細胞から誘導したCAR-T細胞療法の開発金子新
Liver Scientific Frontier2025 2025年3月8日招待有り
10. Generation of therapeutics T cells from iPS cells for cancer immunology 金子新
TIB CATAPULT/LINK-BioBAY TOKYO Kick-off Symposium and Lab Tour 2025年2月20日招待有り
11. 自己と非自己、免疫とがん、そして個別化iPS治療 your cancer,your cell,your cure 金子新
Super Cells Infinite 2025年2月11日招待有り
12. ＜CancerX Innovation＞『これまでになかった治療を届けるには』金子新
World Cancer Week 2025 2025年2月2日招待有り
13. Development of Immune CellTherapy using iPS cell Technology 金子新
2024CNU International Symposium on Medical Science（CNU-ISMS） 2024年11月22日招待有り
14. Tackling cancer treatment using iPS cells! 金子新
GASA研修会 2024年11月19日招待有り
15. iPS細胞技術を用いたアロジェニックCAR-T細胞治療の開発金子新
第50回セルセラピーセミナー 2024年11月15日招待有り
16. The generation of T cells from iPSCs for immunotherapy 金子新
1st CCII International Symposium on Immunotherapy and Immunobiology 2024年11月14日招待有り
17. iPS細胞と私たちの生活金子新
神戸市シルバーカレッジ 2024年11月5日招待有り
18. The Generation of T cells from iPS cells for Immunotherapy 金子新
The 33rd Hot Spring Harbor International Symposium − Cutting-Edge Research and Technology in Stem Cells and Reprogramming − 2024年10月29日招待有り
19. Generation of therapeutic immune cells from iPSCs 金子新
第62回日本癌治療学会学術集会 2024年10月25日招待有り
20. iPS 細胞からの免疫細胞再生とその臨床応用に向けて金子新
第227回茨城県内科学会 2024年10月20日招待有り